Stereotactic radiotherapy (SRT)

Status
Ongoing
Project acroniem
SRT
Introduction
Radiotherapy is a technique that can be used separately or in combination with other treatments, e.g. surgery, chemotherapy and immunotherapy, in the treatment of cancer. Radiotherapy is used for several purposes: (1) to cure the patient (curative radiotherapy), (2) to reduce the risk of relapse after surgery (adjuvant or supplementary radiotherapy), (3) to simplify surgery and/or improve its outcomes, or (4) to reduce symptoms when no more treatment is possible (palliative radiotherapy).
Stereotactic radiotherapy (SRT) is a technique in which tumours are irradiated very precisely with a high dose and for a limited number of sessions.

Objective
Since 1 January 2020, four new services for SRT have been included in the nomenclature of medical services for radiotherapy. These services include treatment of intracerebral lesions consisting of brain tumours, brain metastases and arteriovenous malformation on the one hand and extracerebral lesions consisting of primary tumours and (oligo)metastases on the other (limited to a maximum of 5 lesions).
Compulsory registration with the Belgian Cancer Registry (BCR) is a requirement for financial reimbursement of the new services by the Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) (National Institute for Health and Disability Insurance).

Financial support and partners
This registration project is run in collaboration with the RIZIV.

Contact
For more information about this registration project, contact stereotacticrt@kankerregister.org.